L. Giurgea

Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial

J. Baptist Trimbos, Ignace Vergote, Giorgio Bolis et al. · JNCI Journal of the National Cancer Institute · 2003 · 679 citations · Full text

Rituximab Maintenance Treatment of Relapsed/Resistant Follicular Non-Hodgkin's Lymphoma: Long-Term Outcome of the EORTC 20981 Phase III Randomized Intergroup Study

Marinus H. J. van Oers, M. van Glabbeke, L. Giurgea et al. · Journal of Clinical Oncology · 2010 · 336 citations

Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy

Martine Piccart, Anne Floquet, Giovanna Scarfone et al. · International Journal of Gynecological Cancer · 2003 · 112 citations

<i>BCL-2/IgH</i> Polymerase Chain Reaction Status at the End of Induction Treatment Is Not Predictive for Progression-Free Survival in Relapsed/Resistant Follicular Lymphoma: Results of a Prospective Randomized EORTC 20981 Phase III Intergroup Study

Marinus H. J. van Oers, Evelyn Tönnissen, M. van Glabbeke et al. · Journal of Clinical Oncology · 2010 · 52 citations · Full text

Long-term update of the 24954 EORTC phase III trial on larynx preservation

B. Henriques de Figueiredo, Catherine Fortpied, Jessica Menis et al. · European Journal of Cancer · 2016 · 43 citations

Laryngectomy, Laryngology, Otorhinolaryngology +6